South Korea expands probe into asbestos-tainted talc pills
This article was originally published in The Gold Sheet
Executive Summary
South Korea's FDA has announced that it will expand its investigation into how asbestos-tainted talc slipped into the manufacturing process for solid oral dosage forms. The talc was used to prevent the pills from sticking to each other in the production process. KFDA's expanded examinations came after an earlier announcement that it had found cancer-causing asbestos in baby powder made by eight companies, who later recalled the products after tendering their apologies to the buyers. However the agency has been criticized for not acting quickly enough and has taken heat from the public for not taking proper safety action even though the agency was warned of these risks in a report five years ago